nodes	percent_of_prediction	percent_of_DWPC	metapath
Treprostinil—Local swelling—Hydrochlorothiazide—nephrolithiasis	0.0743	0.0986	CcSEcCtD
Treprostinil—PTGIR—Endothelin Pathways—ADCY10—nephrolithiasis	0.0672	0.272	CbGpPWpGaD
Treprostinil—Gout—Hydrochlorothiazide—nephrolithiasis	0.0278	0.0369	CcSEcCtD
Treprostinil—Bone pain—Hydrochlorothiazide—nephrolithiasis	0.0271	0.036	CcSEcCtD
Treprostinil—Wheezing—Hydrochlorothiazide—nephrolithiasis	0.0252	0.0335	CcSEcCtD
Treprostinil—Ecchymosis—Hydrochlorothiazide—nephrolithiasis	0.0235	0.0312	CcSEcCtD
Treprostinil—Pain in extremity—Hydrochlorothiazide—nephrolithiasis	0.0188	0.025	CcSEcCtD
Treprostinil—Hypokalaemia—Hydrochlorothiazide—nephrolithiasis	0.0171	0.0228	CcSEcCtD
Treprostinil—Influenza—Hydrochlorothiazide—nephrolithiasis	0.0163	0.0216	CcSEcCtD
Treprostinil—Pneumonia—Hydrochlorothiazide—nephrolithiasis	0.0146	0.0194	CcSEcCtD
Treprostinil—PPARD—NRF2 pathway—SLC2A9—nephrolithiasis	0.0145	0.0586	CbGpPWpGaD
Treprostinil—Urinary tract infection—Hydrochlorothiazide—nephrolithiasis	0.0141	0.0187	CcSEcCtD
Treprostinil—Haematuria—Hydrochlorothiazide—nephrolithiasis	0.0138	0.0184	CcSEcCtD
Treprostinil—Epistaxis—Hydrochlorothiazide—nephrolithiasis	0.0137	0.0182	CcSEcCtD
Treprostinil—Sinusitis—Hydrochlorothiazide—nephrolithiasis	0.0136	0.0181	CcSEcCtD
Treprostinil—Bradycardia—Hydrochlorothiazide—nephrolithiasis	0.0133	0.0176	CcSEcCtD
Treprostinil—Rhinitis—Hydrochlorothiazide—nephrolithiasis	0.0131	0.0173	CcSEcCtD
Treprostinil—Pharyngitis—Hydrochlorothiazide—nephrolithiasis	0.0129	0.0172	CcSEcCtD
Treprostinil—P2RY12—G alpha (i) signalling events—RGS14—nephrolithiasis	0.0129	0.0523	CbGpPWpGaD
Treprostinil—Oedema peripheral—Hydrochlorothiazide—nephrolithiasis	0.0128	0.017	CcSEcCtD
Treprostinil—Flushing—Hydrochlorothiazide—nephrolithiasis	0.0121	0.0161	CcSEcCtD
Treprostinil—Erythema—Hydrochlorothiazide—nephrolithiasis	0.0113	0.0151	CcSEcCtD
Treprostinil—Tension—Hydrochlorothiazide—nephrolithiasis	0.0111	0.0148	CcSEcCtD
Treprostinil—Nervousness—Hydrochlorothiazide—nephrolithiasis	0.011	0.0146	CcSEcCtD
Treprostinil—Back pain—Hydrochlorothiazide—nephrolithiasis	0.011	0.0146	CcSEcCtD
Treprostinil—Muscle spasms—Hydrochlorothiazide—nephrolithiasis	0.0109	0.0145	CcSEcCtD
Treprostinil—Ill-defined disorder—Hydrochlorothiazide—nephrolithiasis	0.0105	0.014	CcSEcCtD
Treprostinil—Anaemia—Hydrochlorothiazide—nephrolithiasis	0.0105	0.0139	CcSEcCtD
Treprostinil—Angioedema—Hydrochlorothiazide—nephrolithiasis	0.0104	0.0138	CcSEcCtD
Treprostinil—Malaise—Hydrochlorothiazide—nephrolithiasis	0.0102	0.0136	CcSEcCtD
Treprostinil—Syncope—Hydrochlorothiazide—nephrolithiasis	0.0102	0.0135	CcSEcCtD
Treprostinil—Palpitations—Hydrochlorothiazide—nephrolithiasis	0.01	0.0133	CcSEcCtD
Treprostinil—Loss of consciousness—Hydrochlorothiazide—nephrolithiasis	0.00997	0.0132	CcSEcCtD
Treprostinil—Cough—Hydrochlorothiazide—nephrolithiasis	0.0099	0.0131	CcSEcCtD
Treprostinil—Chest pain—Hydrochlorothiazide—nephrolithiasis	0.00966	0.0128	CcSEcCtD
Treprostinil—Myalgia—Hydrochlorothiazide—nephrolithiasis	0.00966	0.0128	CcSEcCtD
Treprostinil—Arthralgia—Hydrochlorothiazide—nephrolithiasis	0.00966	0.0128	CcSEcCtD
Treprostinil—Anxiety—Hydrochlorothiazide—nephrolithiasis	0.00962	0.0128	CcSEcCtD
Treprostinil—Discomfort—Hydrochlorothiazide—nephrolithiasis	0.00954	0.0127	CcSEcCtD
Treprostinil—Oedema—Hydrochlorothiazide—nephrolithiasis	0.00926	0.0123	CcSEcCtD
Treprostinil—P2RY12—Platelet activation, signaling and aggregation—DGKH—nephrolithiasis	0.00916	0.0371	CbGpPWpGaD
Treprostinil—Shock—Hydrochlorothiazide—nephrolithiasis	0.00911	0.0121	CcSEcCtD
Treprostinil—Thrombocytopenia—Hydrochlorothiazide—nephrolithiasis	0.00906	0.012	CcSEcCtD
Treprostinil—Tachycardia—Hydrochlorothiazide—nephrolithiasis	0.00903	0.012	CcSEcCtD
Treprostinil—PTGIR—G alpha (s) signalling events—PTH—nephrolithiasis	0.00885	0.0358	CbGpPWpGaD
Treprostinil—Anorexia—Hydrochlorothiazide—nephrolithiasis	0.00882	0.0117	CcSEcCtD
Treprostinil—Hypotension—Hydrochlorothiazide—nephrolithiasis	0.00865	0.0115	CcSEcCtD
Treprostinil—Musculoskeletal discomfort—Hydrochlorothiazide—nephrolithiasis	0.00843	0.0112	CcSEcCtD
Treprostinil—Insomnia—Hydrochlorothiazide—nephrolithiasis	0.00837	0.0111	CcSEcCtD
Treprostinil—Paraesthesia—Hydrochlorothiazide—nephrolithiasis	0.00831	0.011	CcSEcCtD
Treprostinil—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.00825	0.011	CcSEcCtD
Treprostinil—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.00815	0.0108	CcSEcCtD
Treprostinil—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.00805	0.0107	CcSEcCtD
Treprostinil—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.00798	0.0106	CcSEcCtD
Treprostinil—Pain—Hydrochlorothiazide—nephrolithiasis	0.00792	0.0105	CcSEcCtD
Treprostinil—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.00763	0.0101	CcSEcCtD
Treprostinil—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.00757	0.0101	CcSEcCtD
Treprostinil—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.00732	0.00972	CcSEcCtD
Treprostinil—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.00732	0.00972	CcSEcCtD
Treprostinil—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.00664	0.00882	CcSEcCtD
Treprostinil—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.00655	0.0087	CcSEcCtD
Treprostinil—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.00633	0.00841	CcSEcCtD
Treprostinil—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.00612	0.00813	CcSEcCtD
Treprostinil—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.00589	0.00782	CcSEcCtD
Treprostinil—P2RY12—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00585	0.0237	CbGpPWpGaD
Treprostinil—Rash—Hydrochlorothiazide—nephrolithiasis	0.00584	0.00775	CcSEcCtD
Treprostinil—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.00583	0.00774	CcSEcCtD
Treprostinil—Headache—Hydrochlorothiazide—nephrolithiasis	0.0058	0.0077	CcSEcCtD
Treprostinil—Nausea—Hydrochlorothiazide—nephrolithiasis	0.0055	0.0073	CcSEcCtD
Treprostinil—PTGIR—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00539	0.0218	CbGpPWpGaD
Treprostinil—P2RY12—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00501	0.0203	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—SLC7A9—nephrolithiasis	0.00472	0.0191	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—DGKH—nephrolithiasis	0.00472	0.0191	CbGpPWpGaD
Treprostinil—PTGIR—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00461	0.0187	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—RGS14—nephrolithiasis	0.00442	0.0179	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—SLC7A9—nephrolithiasis	0.00435	0.0176	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—DGKH—nephrolithiasis	0.00435	0.0176	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—RGS14—nephrolithiasis	0.00407	0.0165	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—RGS14—nephrolithiasis	0.00401	0.0162	CbGpPWpGaD
Treprostinil—P2RY12—GPCR ligand binding—CHRM3—nephrolithiasis	0.00382	0.0155	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—RGS14—nephrolithiasis	0.00369	0.0149	CbGpPWpGaD
Treprostinil—PTGIR—GPCR ligand binding—CHRM3—nephrolithiasis	0.00351	0.0142	CbGpPWpGaD
Treprostinil—P2RY12—GPCR ligand binding—PTH—nephrolithiasis	0.00349	0.0141	CbGpPWpGaD
Treprostinil—PTGIR—GPCR ligand binding—PTH—nephrolithiasis	0.00321	0.013	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—DGKH—nephrolithiasis	0.00298	0.0121	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—GRHPR—nephrolithiasis	0.00286	0.0116	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—ADCY10—nephrolithiasis	0.00279	0.0113	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—DGKH—nephrolithiasis	0.00275	0.0111	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—DGKH—nephrolithiasis	0.00271	0.011	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—ADCY10—nephrolithiasis	0.00257	0.0104	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—AGXT—nephrolithiasis	0.00255	0.0103	CbGpPWpGaD
Treprostinil—CYP2C9—Biological oxidations—SLC26A1—nephrolithiasis	0.00255	0.0103	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—DGKH—nephrolithiasis	0.00249	0.0101	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—RGS14—nephrolithiasis	0.00237	0.00959	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—RGS14—nephrolithiasis	0.00218	0.00883	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—APRT—nephrolithiasis	0.00217	0.00879	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—SLC26A1—nephrolithiasis	0.00217	0.00879	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—CHRM3—nephrolithiasis	0.00216	0.00873	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—CHRM3—nephrolithiasis	0.00199	0.00804	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—PTH—nephrolithiasis	0.00197	0.00799	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—CHRM3—nephrolithiasis	0.00196	0.00793	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—PTH—nephrolithiasis	0.00182	0.00735	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—CHRM3—nephrolithiasis	0.0018	0.0073	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—PTH—nephrolithiasis	0.00179	0.00725	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—PTH—nephrolithiasis	0.00165	0.00668	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.0016	0.00648	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—DGKH—nephrolithiasis	0.0016	0.00648	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—AQP1—nephrolithiasis	0.00155	0.00626	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—DGKH—nephrolithiasis	0.00147	0.00596	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.00147	0.00596	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—CHRM3—nephrolithiasis	0.0014	0.00566	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CHRM3—nephrolithiasis	0.00116	0.00469	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CHRM3—nephrolithiasis	0.00107	0.00431	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—PTH—nephrolithiasis	0.00106	0.00429	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—PTH—nephrolithiasis	0.000974	0.00394	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—GRHPR—nephrolithiasis	0.000576	0.00233	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—SPP1—nephrolithiasis	0.000531	0.00215	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—AGXT—nephrolithiasis	0.000513	0.00208	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—SPP1—nephrolithiasis	0.000489	0.00198	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—APRT—nephrolithiasis	0.000436	0.00177	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—SLC26A1—nephrolithiasis	0.000436	0.00177	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—AQP1—nephrolithiasis	0.000311	0.00126	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—CHRM3—nephrolithiasis	0.000281	0.00114	CbGpPWpGaD
